Acton, MA, United States of America

Pat Oliver-Shaffer

USPTO Granted Patents = 1 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Pat Oliver-Shaffer: Advancing Low Molecular Weight Heparin Technologies

Introduction

Pat Oliver-Shaffer is an accomplished inventor based in Acton, Massachusetts. With a keen focus on pharmaceuticals, particularly in the realm of low molecular weight heparins, he has made notable contributions to the medical field. His innovative work aims to enhance the properties and utility of heparin compositions.

Latest Patents

Pat Oliver-Shaffer holds a significant patent for a "Low molecular weight heparin composition and uses thereof." This patent describes preparations of low molecular weight heparins (LMWHs) that possess improved characteristics, providing a substantial clinical advantage. The patent outlines methods for creating these preparations, as well as analytical techniques for assessing starting materials, intermediates, and final products during the production process of the LMWH preparations.

Career Highlights

Currently employed at Momenta Pharmaceuticals, Inc., Pat Oliver-Shaffer has established himself as a valuable asset within the organization. His work emphasizes innovation in pharmaceutical formulations and therapeutic applications, enhancing patient care through his research and development endeavors.

Collaborations

Throughout his career, Pat has collaborated with talented colleagues, including Zachary Shriver and Mallikarjun Sundaram. These partnerships have fostered a collaborative environment that promotes the exchange of ideas and accelerates the development of groundbreaking medical advancements.

Conclusion

In conclusion, Pat Oliver-Shaffer exemplifies the spirit of innovation within the pharmaceutical industry. His focused contributions to low molecular weight heparin technology showcase not only his expertise as an inventor but also his commitment to improving health outcomes for patients. With a strong patent backing his innovative work, Pat continues to pave the way for future advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…